Specialized Medical Company’s (SMC) retail offering was 1.45x oversubscribed, booking roughly SAR 542.2 mn in orders from individual investors, according to a filing to Tadawul. The Riyadh-based private healthcare provider priced its shares at SAR 25 a pop — the top of the range it was guiding on — after its institutional offering was nearly 65x oversubscribed, with orders exceeding SAR 121.4 bn.

Proceeds: SMC’s main market IPO stands to raise some SAR 1.9 bn, implying a market cap of SAR 6.3 bn at listing. The firm’s selling shareholders will rake in net proceeds from the share sale, with no new shares being issued for the IPO.

What’s next? Final allocations will now take place on Tuesday, 24 June, after retailsubscriptions were postponed late last month. There’s no word yet on when SMC’s shares will hit the market.

ICYMI- SMC is taking a 30% stake to market in one of the Kingdom’s largest market debuts this year, trailing behind Flynas’ SAR 4.1 bn listing and Umm Al Qura for Development’s SAR 2 bn IPO in March.

Housekeeping notes: SMC flagged a discrepancy in its financial disclosures and moved toreverse a SAR 200 mn dividend payout, requiring shareholders to return the funds by Monday, 30 June.

ADVISORS- Our friends at EFG Hermes are quarterbacking the transaction as joint financial advisors, underwriters, and bookrunners, alongside SNB Capital, which is also serving as lead manager. Receiving agents include Al Rajhi Capital, BSF Capital, Alinma Investment, and Riyad Capital, among others.

ALSO IN THE PIPELINE-